Learn more about what Canon Medical will be showcasing virtually at RSNA 2021.
RSNA 2021 is quickly approaching as members of the greater radiology healthcare community prepare to immerse themselves in five days of scientific sessions, key lectures, and exciting product demonstrations.
Diagnostic Imaging sat down with Canon Medical's David Hashimoto, Senior Director, Full Line BUs and Solutions Marketing, to learn more about what Canon has planned for their virtual participation in RSNA 2021.
Canon Medical will offer attendees--both in-person and virtual--an immersive experience that includes live product demonstrations and scheduled briefings with Canon Medical experts across the breadth of their portfolio, including CT, molecular imaging, MRI, ultrasound, X-ray, interventional radiology, and healthcare IT.
For the latest coverage of RSNA 2021, click here.
In addition, Canon Medical will also be hosting a roundtable discussion, "State of AI in Radiology Today," featuring a distinguished panel of speakers who will discuss the financial, technical, clinical, and regulatory considerations of applying AI in today's radiology practice and in the future.
Those interested in the roundtable discussion can pre-register here.
To learn more about what Canon Medical will be sharing at RSNA 2021, click here.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.